financetom
Business
financetom
/
Business
/
McCoy Global Q4 Revenue increased 8% to $19.7 Million; Doubled Its Quarterly Dividend
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
McCoy Global Q4 Revenue increased 8% to $19.7 Million; Doubled Its Quarterly Dividend
Mar 14, 2024 5:47 AM

08:20 AM EDT, 03/14/2024 (MT Newswires) -- McCoy Global Inc. ( MCCRF ) , which rose 2.6% yesterday, on Thursday reported fourth quarter revenue increased 8% to $19.7 million, compared to $18.3 million in 2022, driven by strong demand for the newly commercialized smart products, particularly McCoy's Flush Mount Spider (FMS). It also reported net earnings of $2.7 million, compared to net earnings of $7.3 million in 2022, with the comparative period benefitting from a $3.9 million gain on sale and leaseback of McCoy's facility in Cedar Park, TX, and $1.0 million recovery of income taxes

MCB also announced the doubling of its quarterly cash dividend to $0.02 per common share payable on April 15, 2024, to shareholders of record as of close of business on March 31, 2024.

"McCoy's strong fourth quarter results reflect the successful execution of our growth strategy. McCoy's revenue and adjusted EBITDA was driven by robust demand for the newly commercialized smart products we invested in under our Digital Technology Roadmap initiative, with particular emphasis on the success of the Flush Mount Spider (FMS) in the North American land market in Q4," said Jim Rakievich, President & CEO of McCoy, in a statement.

"Looking ahead, oil & gas market fundamentals remain robust for international markets, especially in the MENA region. Though timing and product mix of customer purchase commitments may result in quarter-to-quarter fluctuations in revenues and gross margins, we anticipate sustained success beyond drilling activity cycles as adoption of our smart technologies continues to accelerate."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hewlett Packard Enterprise Ships First Nvidia Grace Blackwell System
Hewlett Packard Enterprise Ships First Nvidia Grace Blackwell System
Feb 13, 2025
10:28 AM EST, 02/13/2025 (MT Newswires) -- Hewlett Packard Enterprise ( HPE ) said Thursday that it has shipped its first Nvidia ( NVDA ) Grace Blackwell System, the NVIDIA GB200 NVL72 system. The company said the rack-scale system features direct liquid cooling technology and is designed for the deployment of large and complex artificial intelligence clusters. Hewlett Packard Enterprise...
Crocs Issues Upbeat Full-Year Earnings Outlook as Fourth-Quarter Results Top Estimates
Crocs Issues Upbeat Full-Year Earnings Outlook as Fourth-Quarter Results Top Estimates
Feb 13, 2025
10:35 AM EST, 02/13/2025 (MT Newswires) -- Crocs ( CROX ) issued an upbeat full-year earnings outlook on Thursday as the shoemaker reported better-than-expected fourth-quarter results. The company anticipates per-share adjusted earnings to be in a range of $12.70 to $13.15 for 2025 on annual revenue growth of about 2% to 2.5%. The current consensus on FactSet is for non-GAAP...
Mexico could file suit against Google for 'Gulf of Mexico' name change
Mexico could file suit against Google for 'Gulf of Mexico' name change
Feb 13, 2025
MEXICO CITY, Feb 13 (Reuters) - Mexican President Claudia Sheinbaum on Thursday urged Google to reconsider its decision to rename the Gulf of Mexico the Gulf of America for U.S. users, adding the country could file a civil suit against the firm if necessary. Google changed the name for U.S. users of Google Maps to reflect the decision by the...
Conduit Pharmaceuticals, Charles River Laboratories Partner to Evaluate Potential Lupus Treatment
Conduit Pharmaceuticals, Charles River Laboratories Partner to Evaluate Potential Lupus Treatment
Feb 13, 2025
10:35 AM EST, 02/13/2025 (MT Newswires) -- Conduit Pharmaceuticals ( CDT ) said Thursday it partnered with Charles River Laboratories International ( CRL ) to evaluate its AZD1656 drug candidate and its derivatives in a preclinical model of systemic lupus erythematosus, as part of its strategy to develop potential immunotherapies for autoimmune disorders. Financial terms of the collaboration were not...
Copyright 2023-2026 - www.financetom.com All Rights Reserved